Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × OTHER × Injections, Subcutaneous × Clear all

Phase

Status

Unknown 1 Terminated 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 209 Radiotherapy 183 Carboplatin 155 Gemcitabine 151 Cisplatin 146 Bevacizumab 139 Docetaxel 137 Paclitaxel 122 Capecitabine 121 Rituximab 119 pembrolizumab 117 Oxaliplatin 103 Nivolumab 103 Dexamethasone 102 Fluorouracil 100 fludarabine 88 Doxorubicin 86 Radiosurgery 83 Etoposide 83 Cytarabine 83 Irinotecan 81 Lenalidomide 79 fludarabine phosphate 78 Leucovorin 77 Filgrastim 77 Radiation 75 Magnetic Resonance Spectroscopy 75 Bortezomib 71 Temozolomide 65 Pemetrexed 65

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04675827 2024-12-04

Decrescendo

Jules Bordet Institute

Phase 2 Terminated

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡